Sponsor:
UI Contact:
Updated Date:
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
General Notices
- Notice of Pre-Application Webinar for RFA-AG-24-004 "Estimating the Monetary Costs of Dementia in the United States (U01 Clinical Trial Not Allowed)"
(NOT-AG-23-002)
National Institute on Aging
- Notice of Pre-Application Webinar for RFA-AG-24-012 and RFA-AG-24-013 on Postbaccalaureate and Summer Research Programs in AD/ADRD
(NOT-AG-23-009)
National Institute on Aging
- Notice of Pre-Application Webinar for RFA-DK-22-038, Pilot Interventions to Integrate Social Care and Medical Care to Improve Health Equity (R01- Clinical Trial Required)
(NOT-DK-23-014)
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of Changes to RFA-ES-23-007 "Exploratory Grants for Climate Change and Health Research Center Development (P20 Clinical Trial Optional)"
(NOT-ES-23-009)
National Institute of Environmental Health Sciences
- Notice of Informational Webinar on the NIGMS U-RISE and MARC Programs (T34)
(NOT-GM-23-037)
National Institute of General Medical Sciences
- NHLBI Notice of Clarification and Availability of Frequently Asked Questions (FAQs) for RFA-HL-23-008 and RFA-HL-23-009 "NHLBI SBIR Phase IIB Small Market Awards"
(NOT-HL-23-082)
National Heart, Lung, and Blood Institute
- Notice of Upcoming Prize Competition Announcement for the TARGETED (Targeted Genome Editor Delivery) Challenge
(NOT-RM-23-008)
Office of Strategic Coordination (Common Fund)
- Request for Information (RFI): Inviting comments and suggestions on the development of a EUREKA prize for early prediction of Alzheimer's disease and related dementias (AD/ADRD)
(NOT-AG-23-012)
National Institute on Aging
- Request for Information (RFI): Inviting input on use of a term like preaddiction for identifying and intervening in substance misuse and mild/early-stage substance use disorder
(NOT-DA-23-019)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
Notice of Changes to Funding Opportunities
- Notice to Extend the Expiration Date of PAR-20-309 "Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required)
(NOT-AG-23-014)
National Institute on Aging
- Notice to Extend the Expiration Date for PA-20-135, Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)
(NOT-OD-23-104)
National Institutes of Health
Notices of Intent to Publish
- Notice of Intent to Publish Funding Opportunity Announcement for Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IMPACT-MH) Mechanism (U01 Clinical Trial Optional)
(NOT-MH-23-195)
National Institute of Mental Health
- Notice of Intent to Publish Funding Opportunity Announcement for Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IMPACT-MH): Data Coordinating Center (U24 Clinical Trial Not Allowed)
(NOT-MH-23-196)
National Institute of Mental Health
- Notice of Intent to Publish a Funding Opportunity Announcement for Biotypes of CNS complications in people living with HIV (P01 Clinical Trial Not Allowed)
(NOT-MH-23-210)
National Institute of Mental Health
National Institute on Drug Abuse
- Notice of Intent to Publish a Funding Opportunity for Emergency Medicine Research Career Development Program in the Neurological Sciences (EMRCDP-NS) (K12 - No Independent Clinical Trial Allowed)
(NOT-NS-23-065)
National Institute of Neurological Disorders and Stroke
Requests for Proposal
- Notice of Request for Proposals (RFP), Solicitation 75N91023R00034: NATIONAL CANCER INSTITUTE (NCI) SMALL BUSINESS INNOVATION RESEARCH (SBIR) INNOVATIVE CONCEPT AWARD PROGRAM
(NOT-CA-23-050)
National Cancer Institute
Notices of Special Interest
- Notice of Special Interest (NOSI): Promoting Health, Safety, and Recovery Training following Declared Disasters in 2022 (Admin Supp Clinical Trial Not Allowed)
(NOT-ES-23-007)
National Institute of Environmental Health Sciences
- Notice of Special Interest (NOSI): Availability of Administrative Supplements to IDeA Awards to Fund Team Science Development Projects
(NOT-GM-23-034)
National Institute of General Medical Sciences
- Notice of Special Interest (NOSI): Administrative Supplements to Encourage Research in Valvular Heart Disease (CAROL Act)
(NOT-HL-23-078)
National Heart, Lung, and Blood Institute
- Notice of Special Interest (NOSI): Administrative Supplements to Support Collaborative HIV/AIDS Research Projects at NIMHD-Funded Research Centers in Minority Institutions (RCMI)
(NOT-MD-23-007)
National Institute on Minority Health and Health Disparities
National Institute of Allergy and Infectious Diseases
Office of Research on Women's Health
Funding Opportunities
- NIH Administrative Supplements to Recover Losses due to Hurricanes Fiona and Ian Under the Consolidated Appropriations Act, 2023 (Admin Supp Clinical Trial Optional)
(PA-23-134)
National Institutes of Health
- Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional)
(PAR-23-122)
National Institute of General Medical Sciences
National Center for Complementary and Integrative Health
National Eye Institute
National Human Genome Research Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke
National Library of Medicine
Office of Behavioral and Social Sciences Research
Office of the Director, NIH
Office of Research on Women's Health
- Entry-Level Modules (ELM) for Training the Genomics Research Workforce (R25-Clinical Trial Not Allowed)
(PAR-23-123)
National Human Genome Research Institute
National Cancer Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Biological Testing Facility (X01 Clinical Trial Not Allowed)
(PAR-23-128)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Blood Brain Barrier Response to Antibodies Targeting Beta-Amyloid (R01 - Clinical Trial Not Allowed)
(PAR-23-140)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
- Estimating the Monetary Costs of Dementia in the United States (U01 Clinical Trial Not Allowed)
(RFA-AG-24-004)
National Institute on Aging
- Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Real-World Data Platform (U54 Clinical Trial Optional)
(RFA-AG-24-009)
National Institute on Aging
National Institute of Neurological Disorders and Stroke
- Limited Competition: The Health and Retirement Study and Harmonized Cognitive Assessment Protocol (U01 Clinical Trial Not Allowed)
(RFA-AG-24-010)
National Institute on Aging
- Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Flaviviridae and Togaviridae (U19 Clinical Trial Not Allowed)
(RFA-AI-23-019)
National Institute of Allergy and Infectious Diseases
- Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Bunyavirales, Paramyxoviridae and Picornaviridae (U19 Clinical Trial Not Allowed)
(RFA-AI-23-020)
National Institute of Allergy and Infectious Diseases
- Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network - Coordination and Data Sharing Center (CDSC) (UG3/UH3 Clinical Trial Not Allowed)
(RFA-AI-23-021)
National Institute of Allergy and Infectious Diseases
- Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit (U24 Clinical Trial Not Allowed)
(RFA-CA-23-031)
National Cancer Institute
- NIBIB Biomaterials Network Technology Development Coordinating Center (U24 Clinical Trial Not Allowed)
(RFA-EB-23-002)
National Institute of Biomedical Imaging and Bioengineering
- Systematic Review of Clinical Outcome Assessments (COAs) for Communication Brain-Computer Interface Devices (cBCIs) in Amyotrophic Lateral Sclerosis (ALS) (UH2/UH3) Clinical Trials Not Allowed
(RFA-FD-23-030)
Food and Drug Administration
- BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed)
(RFA-NS-24-004)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): January 20, 2026 - BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed)
(RFA-NS-24-005)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): January 20, 2026 - NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
(RFA-RM-23-004)
Office of Strategic Coordination (Common Fund)
Application Receipt Date(s): September 08, 2023
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu(link sends e-mail)(link sends e-mail) or 313-335-2123, or email Ann Ricketts at ann-ricketts@uiowa.edu(link sends e-mail)(link sends e-mail) or Lynn Hudachek at lynn-hudachek@uiowa.edu(link sends e-mail)(link sends e-mail).